Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report

BACKGROUND: Gemcitabine is an antimetabolite used in the treatment of pancreatic cancer. One of the side effects of gemcitabine is vascular toxicity. Here, we report the case of a patient treated with gemcitabine who had peripheral vascular disease concomitant with a prolonged antitumor response. CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabien, Moinard-Butot, Elodie, Poprawa, Anna, Schohn, Addeo, Pietro, Meher, Benabdelghani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013109/
https://www.ncbi.nlm.nih.gov/pubmed/36926125
http://dx.doi.org/10.12998/wjcc.v11.i6.1372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013109/
https://www.ncbi.nlm.nih.gov/pubmed/36926125
http://dx.doi.org/10.12998/wjcc.v11.i6.1372

Ejemplares similares